Listen "Clinical trials - who, what, where, why, how?"
Episode Synopsis
Join us for a rapid dive into clinical trials, the "gold standard" of medical progress! These studies are fundamental to evaluating new treatments, generating crucial data on dosage, safety, and efficacy.We'll cover:The Phases: From Phase 0 (exploratory, first-in-human) to Phase I (safety, dosage in 20-80 people), Phase II (preliminary efficacy, 100-300 people), and Phase III (confirmation, large scale, 1,000-3,000 people for regulatory approval). Phase IV continues post-market surveillance.The Blueprint: Every trial follows a comprehensive protocol, its "operating manual," ensuring scientific validity, ethical compliance, and consistent data collection.Ethical Pillars: Informed consent ensures participants understand and voluntarily agree to join, overseen by Institutional Review Boards (IRBs), which are independent ethics committees that review and approve studies to protect human subjects' rights and welfare.Key Hurdles: Trials face significant challenges, including ethical and regulatory complexities, difficulties in patient recruitment, and limitations in budget and skilled staff.Tune in to understand why these meticulously conducted studies are essential for new health discoveries, acting as the rigorous proving ground where potential treatments are tested and refined before they can offer hope to millions.
More episodes of the podcast Kudla Cracks It
Who Defines 'Beauty'?
15/08/2025
The "Therapeutic Winter"
12/08/2025
What is a biomarker, and who decides?
11/08/2025
ZARZA We are Zarza, the prestigious firm behind major projects in information technology.